| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.22 | 0.4 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.4 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |